Randomized trials for endovascular treatment of infrainguinal arterial disease: Systematic review and meta-analysis (part 1: Above the knee)

European Journal of Vascular and Endovascular Surgery

Volumn 47, Issue 5, 2014, Pages 524-535

  Jens, S ^a   Conijn, A P ^a   Koelemay, M J W ^a   Bipat, S ^a   Reekers, J A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Critical limb ischemia; Drug eluting balloon; Drug eluting stent; Intermittent claudication; Meta analysis; Percutaneous transluminal angioplasty; Stent; Systematic review

Indexed keywords

NITINOL; PACLITAXEL;

ABOVE THE KNEE ARTERY LESION; AMPUTATION; ARTERY LESION; BARE METAL STENT; CARDIOVASCULAR PROCEDURE; CRITICAL LIMB ISCHEMIA; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; META ANALYSIS; NITINOL STENT; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; REVASCULARIZATION; REVIEW; SYSTEMATIC REVIEW; WALKING;

CRITICAL LIMB ISCHEMIA; DRUG-ELUTING BALLOON; DRUG-ELUTING STENT; INTERMITTENT CLAUDICATION; META-ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STENT; SYSTEMATIC REVIEW;

ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; ENDOVASCULAR PROCEDURES; FEMORAL ARTERY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84898785794     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2014.02.011     Document Type: Review

References (37)

1. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 Suppl. 1 2007 S1 S75
2. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
3. Higgins JPT, Altman DG, Sterne JAC, editors. Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011.
4. G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, and P. Alonso-Coello et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 7650 2008 924 926
5. G. Brancaccio, R. Lombardi, T. Stefanini, P. Torri, D. Russo, and N. Gorji et al. Comparison of embolic load in femoropopliteal interventions: percutaneous transluminal angioplasty versus stenting Vasc Endovascular Surg 46 3 2012 229 235
6. J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, and M. Buchbinder et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 3 2010 267 276
7. J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, and M. Buchbinder et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial J Endovasc Ther 19 1 2012 1 9
8. P. Dick, H. Wallner, S. Sabeti, C. Loewe, W. Mlekusch, and J. Lammer et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions Catheter Cardiovasc Interv 74 7 2009 1090 1095
9. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol;19(6):823-32.
10. R.R. Saxon, J.M. Coffman, J.M. Gooding, E. Natuzzi, and D.J. Ponec Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial J Vasc Interv Radiol 14 3 2003 303 311
11. M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi, and W. Mlekusch et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 18 2006 1879 1888
12. M. Schillinger, S. Sabeti, P. Dick, J. Amighi, W. Mlekusch, and O. Schlager et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting Circulation 115 21 2007 2745 2749
13. S. Sabeti, A. Czerwenka-Wenkstetten, P. Dick, O. Schlager, J. Amighi, and I. Mlekusch et al. Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial J Endovasc Ther 14 4 2007 431 437
14. H. Krankenberg, M. Schluter, H.J. Steinkamp, K. Burgelin, D. Scheinert, and K.L. Schulte et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 3 2007 285 292
15. D. Greenberg, K. Rosenfield, L.A. Garcia, R.H. Berezin, T. Lavelle, and S. Fogleman et al. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial) J Vasc Interv Radiol 15 10 2004 1065 1069
16. N. Chalmers, P.T. Walker, A.M. Belli, A.P. Thorpe, P.S. Sidhu, and G. Robinson et al. Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study Cardiovasc Intervent Radiol 36 2 2013 353 361
17. A. Rastan, H. Krankenberg, I. Baumgartner, E. Blessing, S. Muller-Hulsbeck, and E. Pilger et al. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial Circulation 127 25 2013 2535 2541
18. L. Grenacher, T. Saam, A. Geier, S. Muller-Hulsbeck, M. Cejna, and G.W. Kauffmann et al. PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA) Rofo 176 9 2004 1302 1310
19. J. Grimm, S. Muller-Hulsbeck, T. Jahnke, C. Hilbert, J. Brossmann, and M. Heller Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions J Vasc Interv Radiol 12 8 2001 935 942
20. M. Cejna, S. Thurnher, H. Illiasch, W. Horvath, P. Waldenberger, and K. Hornik et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study J Vasc Interv Radiol 12 1 2001 23 31
21. M. Cejna, M. Schoder, and J. Lammer PTA vs. stent in femoro-popliteal obstruction Radiologe 39 2 1999 144 150
22. Z. Zdanowski, U. Albrechtsson, A. Lundin, T. Jonung, E. Ribbe, and J. Thorne et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study Int Angiol 18 4 1999 251 255
23. D. Vroegindeweij, L.D. Vos, A.V. Tielbeek, J. Buth, and H.C. vd Bosch Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study Cardiovasc Intervent Radiol 20 6 1997 420 425
24. J.P. Becquemin, J.P. Favre, J. Marzelle, C. Nemoz, C. Corsin, and A. Leizorovicz Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study J Vasc Surg 37 3 2003 487 494
25. M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, and H.B. Smouse et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 5 2011 495 504
26. M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, and H.B. Smouse et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies J Am Coll Cardiol 61 24 2013 18
27. M. Werk, S. Langner, B. Reinkensmeier, H.F. Boettcher, G. Tepe, and U. Dietz et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 13 2008 1358 1365
28. G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwalder, and J.P. Beregi et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 7 2008 689 699
29. M. Werk, T. Albrecht, D.R. Meyer, M.N. Ahmed, A. Behne, and U. Dietz et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial Circ Cardiovasc Interv 5 6 2012 831 840
30. F. Fanelli, A. Cannavale, E. Boatta, M. Corona, P. Lucatelli, and A. Wlderk et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial J Endovasc Ther 19 5 2012 571 580
31. J. Lammer, T. Zeller, K.A. Hausegger, P.J. Schaefer, M. Gschwendtner, and S. Mueller-Huelsbeck et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease) J Am Coll Cardiol 62 15 2013 1320 1327
32. S.H. Duda, B. Pusich, G. Richter, P. Landwehr, V.L. Oliva, and A. Tielbeek et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results Circulation 106 12 2002 1505 1509
33. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, and A. Tielbeek et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial J Vasc Interv Radiol 16 3 2005 331 338
34. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, and V. Oliva et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial J Endovasc Ther 13 6 2006 701 710
35. L. Bero Industry sponsorship and research outcome: a Cochrane review JAMA Intern Med 173 7 2013 Apr 8 580 581
36. R.W. Scherer, P. Langenberg, and E.E. von Full publication of results initially presented in abstracts Cochrane Database Syst Rev 2 2007 MR000005
37. U. Ozkan, L. Oguzkurt, and F. Tercan Atherosclerotic risk factors and segmental distribution in symptomatic peripheral artery disease J Vasc Interv Radiol 20 4 2009 437 441